Literature DB >> 19305966

[Current diagnosis and therapy of osteoporosis on the basis of "European guidance 2008"].

R Bartl1, R Gradinger.   

Abstract

Osteoporosis is one of the 10 most important and widespread global diseases. In Germany alone the cost of osteoporosis runs into many billions of Euros. However, it should be noted that in the past 15 years great progress has been made both in diagnosis and in the development of new medications, and this has changed the general perception of and attitude to osteoporosis. It is now taken very seriously and recognised as a national and global disorder which is both preventable and treatable. In spite of this progress, in Europe and especially in Germany, osteoporosis remains an underdiagnosed and undertreated disease. In Germany, only about 10%-15% of patients with manifest osteoporosis are properly treated. However, in addition to national guidelines, there is now a new edition of the "European Position Paper for the Diagnosis and Management of Osteoporosis". This provides physicians treating osteoporosis patients with additional information and therefore more confidence.

Entities:  

Mesh:

Year:  2009        PMID: 19305966     DOI: 10.1007/s00132-008-1404-4

Source DB:  PubMed          Journal:  Orthopade        ISSN: 0085-4530            Impact factor:   1.087


  63 in total

Review 1.  Bone densitometry: the best way to detect osteoporosis and to monitor therapy.

Authors:  P D Miller; C Zapalowski; C A Kulak; J P Bilezikian
Journal:  J Clin Endocrinol Metab       Date:  1999-06       Impact factor: 5.958

Review 2.  Osteoporosis.

Authors:  Philip Sambrook; Cyrus Cooper
Journal:  Lancet       Date:  2006-06-17       Impact factor: 79.321

3.  Relationship between changes in BMD and nonvertebral fracture incidence associated with risedronate: reduction in risk of nonvertebral fracture is not related to change in BMD.

Authors:  Nelson B Watts; Piet Geusens; Ian P Barton; Dieter Felsenberg
Journal:  J Bone Miner Res       Date:  2005-08-08       Impact factor: 6.741

4.  Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025.

Authors:  Russel Burge; Bess Dawson-Hughes; Daniel H Solomon; John B Wong; Alison King; Anna Tosteson
Journal:  J Bone Miner Res       Date:  2007-03       Impact factor: 6.741

5.  Compliance with osteoporosis medications.

Authors:  Daniel H Solomon; Jerry Avorn; Jeffrey N Katz; Joel S Finkelstein; Marilyn Arnold; Jennifer M Polinski; M Alan Brookhart
Journal:  Arch Intern Med       Date:  2005-11-14

6.  Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis.

Authors:  Dennis M Black; Pierre D Delmas; Richard Eastell; Ian R Reid; Steven Boonen; Jane A Cauley; Felicia Cosman; Péter Lakatos; Ping Chung Leung; Zulema Man; Carlos Mautalen; Peter Mesenbrink; Huilin Hu; John Caminis; Karen Tong; Theresa Rosario-Jansen; Joel Krasnow; Trisha F Hue; Deborah Sellmeyer; Erik Fink Eriksen; Steven R Cummings
Journal:  N Engl J Med       Date:  2007-05-03       Impact factor: 91.245

Review 7.  Fundamentals and pitfalls of bone densitometry using dual-energy X-ray absorptiometry (DXA).

Authors:  Nelson B Watts
Journal:  Osteoporos Int       Date:  2004-08-21       Impact factor: 4.507

8.  The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis.

Authors:  Dennis M Black; Susan L Greenspan; Kristine E Ensrud; Lisa Palermo; Joan A McGowan; Thomas F Lang; Patrick Garnero; Mary L Bouxsein; John P Bilezikian; Clifford J Rosen
Journal:  N Engl J Med       Date:  2003-09-20       Impact factor: 91.245

9.  The components of excess mortality after hip fracture.

Authors:  J A Kanis; A Oden; O Johnell; C De Laet; B Jonsson; A K Oglesby
Journal:  Bone       Date:  2003-05       Impact factor: 4.398

10.  Bone mineral density thresholds for pharmacological intervention to prevent fractures.

Authors:  Ethel S Siris; Ya-Ting Chen; Thomas A Abbott; Elizabeth Barrett-Connor; Paul D Miller; Lois E Wehren; Marc L Berger
Journal:  Arch Intern Med       Date:  2004-05-24
View more
  4 in total

1.  [Secondary osteoporosis: pathogenesis, types, diagnostics and therapy].

Authors:  C Bartl; R Bartl
Journal:  Radiologe       Date:  2011-04       Impact factor: 0.635

2.  Does the cement stiffness affect fatigue fracture strength of vertebrae after cement augmentation in osteoporotic patients?

Authors:  Jan Philipp Kolb; Rebecca A Kueny; Klaus Püschel; Andreas Boger; Johannes M Rueger; Michael M Morlock; Gerd Huber; Wolfgang Lehmann
Journal:  Eur Spine J       Date:  2013-05-16       Impact factor: 3.134

3.  Effects of physical therapy on quality of life in osteoporosis patients - a randomized clinical trial.

Authors:  Guido Schröder; Andreas Knauerhase; Guenther Kundt; Hans-Christof Schober
Journal:  Health Qual Life Outcomes       Date:  2012-08-24       Impact factor: 3.186

Review 4.  Bisphosphonate conjugation for bone specific drug targeting.

Authors:  Kristen B Farrell; Alexander Karpeisky; Douglas H Thamm; Shawn Zinnen
Journal:  Bone Rep       Date:  2018-07-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.